Healthcare

Neuren Pharmaceuticals Ltd (ASX:NEU) closed at AUD 21.56 at the close of trading on 6 August 2026, down -0.37% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) …

4DMedical Ltd (ASX:4DX) closed at AUD 4.64 at the close of trading on 6 August 2026, down -1.70% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) gained …

Ansell Ltd (ASX:ANN) closed at AUD 34.57 at the close of trading on 6 August 2026, down -0.29% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) gained …

Cochlear Ltd (ASX:COH) closed at AUD 125.99 at the close of trading on 6 August 2026, up 3.27% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) gained …

Amplia Therapeutics has secured a clinical collaboration with pharmaceutical heavyweight Eli Lilly, a deal that hands the small Melbourne biotech a foothold in lung cancer without draining its modest balance sheet. Announced to the ASX on 4 August 2026, the agreement will see Amplia's …

Osteopore Ltd (ASX: OSX) shares were trading at A$0.0050, up A$0.00050 or 11.11% at 10:13 am on 6 August 2026. The share movement followed the company’s announcement that it has entered into a three-year distribution agreement with Al-Umnia Medical LLC for its orthopaedic products …

Neuren Pharmaceuticals Limited (ASX:NEU) shares were trading at AUD 22.15, up 2.36%, at the time of writing on 6 August 2026. The share price movement occurred during a positive session for healthcare stocks, with investors continuing to monitor biotechnology developments, medical innovation and broader …